Filing Details
- Accession Number:
- 0001179110-10-016948
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-03 12:00:00
- Reporting Period:
- 2010-12-01
- Filing Date:
- 2010-12-03
- Accepted Time:
- 2010-12-03 19:15:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1080014 | Theravance Inc | THRX | Pharmaceutical Preparations (2834) | 943265960 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1302445 | L David Brinkley | Theravance, Inc. 901 Gateway Boulevard South San Francisco CA 94080 | Head Of Business Dev. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-12-01 | 15,275 | $3.10 | 58,359 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-12-01 | 20,000 | $25.07 | 38,359 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2010-12-01 | 15,275 | $0.00 | 15,275 | $3.10 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,789 | 2013-01-24 | No | 4 | M | Direct |
Footnotes
- Immediately exercisable.